Christopher Freeman

Christopher Freeman

Corporate Officer/Principal bei GUARDANT HEALTH, INC.

Vermögen: 274 062 $ am 30.04.2024

50 Jahre
Health Services
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Christopher Freeman

EinheitArt der EinheitIndustrie
Public Company Medical/Nursing Services 28
Public Company Biotechnology 26
Dream Foundation
9
Foundation/Endowment 9

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Christopher Freeman

UnternehmenSektorVerknüpfte PersonenHauptposition
Biotechnology

Ian Clark

Myrtle Potter

Steve Krognes

Troy Cox

Craig Eagle

Sandra Horning

Chief Executive Officer

Chief Operating Officer

Director of Finance/CFO

Sales & Marketing

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Stanford University College/University

Helmy Eltoukhy

Jeremy Bender

AmirAli Talasaz

Chris Takimoto

Mark Genovese

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Corporate Officer/Principal

College/University

Richard Whitley

Janet Dorling

John Sundy

Michael Quigley

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

Harvard Business School College/University

Samir Kaul

Javier Rodriguez

Steve Krognes

Meghan Joyce

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

University of California, Berkeley College/University

Stanley Meresman

Kumud Kalia

Janet Dorling

Undergraduate Degree

Graduate Degree

Masters Business Admin

ILLUMINA, INC. Biotechnology

Jacquie Ross

Helmy Eltoukhy

AmirAli Talasaz

Investor Relations Contact

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Anthony Welters

Jeffrey Bluestone

Corporate Officer/Principal

Corporate Officer/Principal

CYMABAY THERAPEUTICS, INC. Biotechnology

Kenneth F. Boehm

Janet Dorling

Human Resources Officer

Corporate Officer/Principal

POLYCOM INC Electronics/Appliances

Kenneth F. Boehm

Stanley Meresman

Human Resources Officer

Director/Board Member

FORTY SEVEN, INC. Pharmaceuticals: Major

Ian Clark

Chris Takimoto

Director/Board Member

Chief Tech/Sci/R&D Officer

FOUNDATION MEDICINE INC Medical/Nursing Services

Troy Cox

Sandra Horning

Chief Executive Officer

Director/Board Member

KYVERNA THERAPEUTICS, INC. Biotechnology

Ian Clark

Mark Genovese

Chairman

Director/Board Member

ASTRAZENECA PLC Pharmaceuticals: Major

Myrtle Potter

Bahija Jallal

Founder

Corporate Officer/Principal

CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Amy E. Flood

William Guyer

Public Communications Contact

Corporate Officer/Principal

College/University

William Guyer

Nick Mordwinkin

Doctorate Degree

Doctorate Degree

OLEMA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ian Clark

Sandra Horning

Chairman

Director/Board Member

ROCHE HOLDING AG Pharmaceuticals: Major

Steve Krognes

Janet Dorling

Corporate Officer/Principal

Corporate Officer/Principal

Stanford Genome Technology Center

Helmy Eltoukhy

AmirAli Talasaz

Corporate Officer/Principal

Corporate Officer/Principal

Wireless Telecommunications

Anthony Welters

Kumud Kalia

Director/Board Member

Chief Tech/Sci/R&D Officer

Haas School of Business College/University

Jacquie Ross

Janet Dorling

Masters Business Admin

Masters Business Admin

SANOFI Biotechnology

Ian Clark

John Sundy

Sales & Marketing

Director/Board Member

University of Michigan College/University

Samir Kaul

Mani Subramanian

Undergraduate Degree

Graduate Degree

CORVUS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ian Clark

Steve Krognes

Director/Board Member

Director/Board Member

The Johns Hopkins University College/University

Bahija Jallal

Amy E. Flood

Director/Board Member

Graduate Degree

New York University School of Law College/University

Anthony Welters

Vijaya Gadde

Director/Board Member

Director/Board Member

Indiana University-Purdue University College/University

Darl S. Moreland

Undergraduate Degree

J. Reuben Clark Law School College/University

Michael Wiley

Graduate Degree

University of Kentucky College/University

Troy Cox

Undergraduate Degree

University of Missouri College/University

Troy Cox

Masters Business Admin

ARGENX SE Pharmaceuticals: Other

Steve Krognes

Director/Board Member

Miscellaneous Commercial Services

Steve Krognes

Director/Board Member

Genentech Access To Care Foundation

Steve Krognes

Chairman

Brigham Young University College/University

Michael Wiley

Undergraduate Degree

Miscellaneous Commercial Services

Steve Krognes

Director/Board Member

ACCURAY INCORPORATED Medical Specialties

Darl S. Moreland

Compliance Officer

GRITSTONE BIO, INC. Biotechnology

Steve Krognes

Director/Board Member

RLS GLOBAL AB (PUBL) Biotechnology

Steve Krognes

Director/Board Member

DANSKE BANK A/S Major Banks

Steve Krognes

Corporate Officer/Principal

Biotechnology

Michael Wiley

Director/Board Member

ALEXZA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Darl S. Moreland

Corporate Officer/Principal

Pharmaceuticals: Major

Troy Cox

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Steve Krognes

Undergraduate Degree

DENALI THERAPEUTICS INC. Biotechnology

Steve Krognes

Director/Board Member

UCB Pharmaceuticals: Major

Troy Cox

Corporate Officer/Principal

STANDARD BIOTOOLS INC. Miscellaneous Commercial Services

Troy Cox

Chairman

Aventis, Inc.

Troy Cox

Corporate Officer/Principal

Medical/Nursing Services

Craig Eagle

Director/Board Member

Statistik

International

Vereinigte Staaten 45
Vereinigtes Königreich 2
Frankreich 2
Niederlande 2
Schweden 2

Sektoral

Health Technology 22
Consumer Services 16
Commercial Services 7
Health Services 3
Consumer Durables 2

Operativ

Director/Board Member 270
Corporate Officer/Principal 127
Independent Dir/Board Member 72
Chief Executive Officer 37
Undergraduate Degree 37
  1. Börse
  2. Insiders
  3. Christopher Freeman
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT